Demand drops for J&J COVID-19 shots after rare blood clotting problem

Lingering lack of confidence remains following 10-day suspension over rare, but serious, blood clotting problem

Brenda Flanagan, Senior Correspondent | May 18, 2021 | Coronavirus in NJ

COVID-19 vaccinations still lag in some of the state’s most vulnerable communities. The Johnson & Johnson vaccine was touted by the Murphy administration as a way to access hard-to-reach neighborhoods. But confidence in the vaccine appears to be lagging after another 13 blood clots were recently reported in connection with the shot.

WATCH: ‘One and done!’ Johnson & Johnson’s COVID-19 vaccine is back at NJ clinics

MORE: With shots widely available, who’s not getting the vaccine?